Internal Server Error

About Morningside

Morningside is a venture capital firm founded in 1986. It is primarily based out of Newton, United States. As of Apr 2026, Morningside is an active investor, having invested in 174 companies, with 5 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of SimpliFed Overall, Morningside portfolio has seen 4 unicorns, 14 IPOs and 19 acquisitions including key companies like Agora, CRED and BetterUp. A lot of funds co-invest with Morningside, with names like Wellington sharing a substantial percentage of its portfolio. Morningside has team of 26 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A, Series B & 9 more
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months

Morningside's List of Top Investments

Morningside has a portfolio of 174 companies, including 4 unicorns. Their most notable investments are in Semios and Linus Health.Their portfolio spans across United States, China, United Kingdom and 11 more locations. They have invested in Life Sciences, Enterprise Applications, HealthTech and 26 other sectors, across stages such as Series A, Series B  and 9 more. Here is the list of top investments by Morningside:
Cloud based customer engagement platform. It enables users to connect through video, voice, and interactive broadcasting. It provides developers with APIs, to embed real time voice, video, interactive streaming, chat, and artificial intelligence capabilities into applications. It helps businesses and developers create engaging and interactive experiences.

Key facts about Agora

  • Founded Year: 2014
  • Location: Guangzhou (China)
  • Stage: Public
  • Total Funding till date: $55M
  • Employee Count: 501 - 1,000 as on Jul 01, 2024
  • Investors: HTIF, Access Industries and 16 Others
  • Latest Funding Round: Post IPO, May 07, 2022, $*****
  • Highlight: Public

2. CRED

Provider of a platform for managing credit cards and payments. The platform offers tools for payment reminders, fee tracking, spending insights, and benefit maximization. It facilitates payments via various methods, including UPI and credit options. The platform also provides credit score monitoring and data encryption for security.

Key facts about CRED

  • Founded Year: 2018
  • Location: Bengaluru (India)
  • Annual Revenue: ₹2,470Cr as on Mar 31, 2024
  • Valuation: $*****
  • Stage: Series G
  • Total Funding till date: $942M
  • Employee Count: 904 as on Aug 31, 2025
  • Investors: GIC, Dragoneer Investment Group and 90 Others
  • Latest Funding Round: Series G, May 29, 2025, $*****
  • Highlight: Editors' Pick

3. Eko

Eko offers an AI-based platform for remote monitoring of cardiac health. The solution offered by the company collects real-time patient data and analyses it to generate a report for doctors. The report generated aids in providing proper treatment to patients. The company has also developed products like Duo and Core stethoscopes for heart disease monitoring.

Key facts about Eko

  • Founded Year: 2012
  • Location: Oakland (United States)
  • Stage: Series D
  • Total Funding till date: $195M
  • Employee Count: 203 as on Mar 31, 2026
  • Investors: 10x Group, Artis Ventures and 33 Others
  • Latest Funding Round: Grant (prize money), Apr 11, 2025, $*****
  • Highlight: Editors' Pick
League provides a SaaS-based digital platform for employee health benefits. The platform gives employers tools to easily manage their benefits program and deliver healthcare services for employees. The web-based app gives the ability to create personal health spending accounts and tracks employee utilization. It also gives customized offerings for employees, delivered on-site by the best health professionals in the business.

Key facts about League

Provider of an AI-powered platform delivering personalized coaching and development. The platform offers tools for leadership development, manager performance improvement, and resilience building. It delivers coaching to employees at all levels. The platform aims to align workforce potential with business strategy through interconnected products.

Key facts about BetterUp

Morningside's Investments by Stage

Morningside has made 42 investments in Series A stage with an average round size of $23.9M, 36 investments in Series B stage with an average round size of $49.2M and 17 investments in Seed stage with an average round size of $4.49M.
Here are Morningside's investments by stage:
Stage of entry
No. of Investments
Series A
42
Series B
36
Seed
17
Series C
11
Series D
7
Others
7
Breakdown of Morningside's investments by stage of entrySeries A (42)Series B (36)
Note: We have considered here, only first round of investments

Morningside's Investments by Sector

Morningside has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Enterprise Applications, High Tech and Consumer. Notably, it has invested in 141 Tech companies, 119 Enterprise (B2B) companies, 47 Software companies and at least 40 companies focusing on Consumer (B2C).
Here are Morningside's investments by sector:
Sector
No. of Investments
Life Sciences
61
HealthTech
28
Enterprise Applications
27
High Tech
22
Consumer
20
Others
96
Breakdown of Morningside's investments by sectorsLife Sciences (61)HealthTech (28)
Note: We have considered here, only first round of investments

Morningside's Investments by Geography

Morningside has made most investments in United States (77), followed by China where it has made 18 investments.
Here are Morningside's investments by geography:
Country
No. of Investments
United States
77
China
18
United Kingdom
11
Canada
3
France
3
Others
8
Breakdown of Morningside's investments by countriesUnited States (77)China (18)
Note: We have considered here, only first round of investments

Morningside's recent investments

Morningside has made 3 investments in 2026 so far. SimpliFed and Cognito Therapeutics are the latest among them.
Here are the most recent investments by Morningside:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Apr 07, 2026
United States
Series A
6820
Mar 05, 2026
United States
Series C
2211
  [+4]
Feb 05, 2026
United States
Series D
4630
Dec 15, 2025
United States
Series B
1154
  [+8]
Oct 22, 2025
-
Seed
1140

Unicorns in Morningside's Portfolio

Morningside has 4 unicorns in its portfolio - CRED, BetterUp, Everlywell and others. The most recent unicorn in their portfolio is CRED. It became a unicorn in 2021, 1 years after Morningside first invested in it.
Here is a list of unicorns in Morningside's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
79
Provider of a platform for managing credit cards and payments
2018
Bengaluru
Series G
bttowej
71
Provider of an AI-powered platform delivering personalized coaching and development
2013
Austin
Series E
tp{s{vq
60
Provider of home-based diagnostic tests for the detection of various diseases
2014
Austin
Funding Raised
uaaxipq
52
Online platform for booking vacation rentals
2012
Beijing
Series F
wkcykhs

IPOs and Publicly Listed companies in Morningside's Portfolio

14 of Morningside's portfolio companies have become public. Alamar Biosciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2026 at marketcap of $1.14B and Generate Biomedicines got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $2.04B.
Here are Morningside's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Apr 17, 2026
Sep 08, 2021
Series B
2343
Feb 27, 2026
Nov 18, 2021
Series B
5170
Feb 13, 2026
Feb 01, 2015
Series B
3468
Oct 24, 2024
Sep 2015
Seed
8410
Feb 03, 2022
Jun 16, 2020
Series D
3728

Acquired companies in Morningside's Portfolio

19 companies from Morningside's portfolio have been acquired. The most recent acquisition were Apellis Pharmaceuticals in Mar 2026 by Biogen for $5.6B.
Here are Morningside's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 31, 2026
Dec 02, 2014
Series C
9654
Mar 30, 2026
Jun 22, 2015
Series A
3857
Oct 21, 2025
-
-
7456
Aug 20, 2025
Nov 23, 2021
Series B
7201
Aug 05, 2025
Nov 17, 2022
Series A
7806

Team profile of Morningside

Morningside has a team of 26 members including 2 Partners, 1 Venture Partner and 4 Principals located in United States. Morningside's team sits on the board of 2 companies.
Here is a list of top team members in Morningside:
Name
Designation
Location
Board Memberships
Contact Details
Partner
-
Partner
-
-
Venture Partner
-
-
Principal
Boston
-
Principal
Cambridge
-
Principal
Boston
-
Principal
Boston
-

Co-investors of Morningside

Over the past 22 years, 899 investors have co-invested in Morningside's portfolio companies. This includes funds and angels.

  • Invested before MorningsideMorningside, HHS and 376 others have invested in rounds before Morningside. There are 13 companies where Morningside has invested before Morningside and 13 companies where HHS has invested before Morningside.
  • Top Co-investors of Morningside240 investors entered a company along with Morningside. These include investors like Wellington (3 companies).
  • Invested after MorningsideA total of 281 investors have invested in Morningside's portfolio after their investments. Top Investors include 5Y Capital (6 companies), Alpha Wave Global (3 companies) and Orbimed (3 companies).

Recent News related to Morningside

View all news related to Morningside

FAQs about Morningside

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford